Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascale Missy

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Central Nervous System Metastases in Thymic Epithelial Tumors: A Brief Report of Real-World Insight From RYTHMICJose Carlos Benitez, Marie-Ève Boucher, Eric Dansin, et al.
Oncotarget|April 21, 2017
Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective studyMichaël Duruisseaux, Benjamin Besse, Jacques Cadranel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2024
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU studyMarion Ferreira, Aurélie Swalduz, Laurent Greillier, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world studyLionel Falchero, Florian Guisier, Marie Darrason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002Sébastien Couraud, Felipe Vaca-Paniagua, Stéphanie Villar, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Kidney International|November 27, 2009
Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney diseaseErick Denamur, Anne-Lise Delezoide, Corinne Alberti, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Central Nervous System Metastases in Thymic Epithelial Tumors: A Brief Report of Real-World Insight From RYTHMICJose Carlos Benitez, Marie-Ève Boucher, Eric Dansin, et al.
Oncotarget|April 21, 2017
Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective studyMichaël Duruisseaux, Benjamin Besse, Jacques Cadranel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2024
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU studyMarion Ferreira, Aurélie Swalduz, Laurent Greillier, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world studyLionel Falchero, Florian Guisier, Marie Darrason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002Sébastien Couraud, Felipe Vaca-Paniagua, Stéphanie Villar, et al.
Lancet (London, England)|January 19, 2016
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)Fabrice Barlesi, Julien Mazieres, Jean-Philippe Merlio, et al.
Kidney International|November 27, 2009
Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney diseaseErick Denamur, Anne-Lise Delezoide, Corinne Alberti, et al.
Pageof 3